Summary & Overview
HCPCS S5571: Insulin Delivery Device, Disposable Pen, 3 ml Size
HCPCS Level II code S5571 identifies a disposable insulin delivery pen (3 ml size) that includes insulin and the pen device. This supply-level code matters nationally because it appears on pharmacy and outpatient supply claims and affects access, coverage determinations, and cost-sharing for patients who use pen devices for insulin administration. The code captures a common modality for insulin delivery used in ambulatory care and self-management.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for pen-based insulin delivery, typical sites of service (retail pharmacy, outpatient clinics, and home), and the billing and coding implications of dispensing a combined pen-and-insulin supply. The publication also outlines typical modifiers encountered on supply claims and notes where data are not available in the input.
The report provides benchmarks and practical coding context rather than clinical guidance: reimbursement considerations for supply claims, common billing modifiers, and how this HCPCS Level II code integrates into broader diabetes care workflows. Data not available in the input are clearly identified where applicable.
Billing Code Overview
HCPCS Level II code S5571 describes an insulin delivery device, disposable pen (including insulin); 3 ml size. The service represents supply of a single-use, prefilled or disposable pen device containing insulin intended for subcutaneous administration by patients or caregivers.
Service Type: Durable medical supply / drug delivery device
Typical Site of Service: Retail pharmacy, outpatient clinic, or patient home/self-care setting
Clinical & Coding Specifications
Clinical Context
A patient with type 1 or insulin-requiring type 2 diabetes presents to an ambulatory endocrinology clinic, primary care office, or diabetes education center for initiation or replacement of a disposable insulin pen device S5571 (3 mL pen including insulin). The typical workflow includes verification of the prescription, confirmation of insulin type and dose, patient education on pen use and disposal by a certified diabetes educator or clinician, documentation of lot number and device included in the medical record, and counseling on storage and sharps disposal. The device may be furnished at discharge from an observation unit, during a same‑day outpatient visit, or provided as part of home health teaching for patients with new insulin regimens. Insurance eligibility and medical necessity are confirmed prior to dispensing; when provided in a hospital outpatient clinic, the device is documented as a supply item associated with the patient encounter.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier; standard billing | Use when no special circumstances apply to the supply of the disposable pen. |
22 |